Hemophilia Treatment Market

Hemophilia Treatment Market Size, Share & Trends Analysis Report By Disease Type (Von Willebrand Disease, Hemophilia A, Hemophilia B) By Product Type(Plasma-Derived Factor Concentrate, Desmopressin, Antifibrinolytics, Recombinant Factor Concentrate) By Route Of Administration (Nasal Spray, Injectable) By Therapy (Replacement Therapy, Immune Tolerance Induction Therapy, Gene Therapy) By End-User (Online, Hospital Pharmacy, Retail Pharmacy) Based On Region, And Segment Forecasts, 2022- 2028


Report
  • Product Id: BMRC 2114
  • Pages: 300
  • Publish Date: Dec-2022
  • Category: Healthcare
VishalSawant
Vishal Sawant
Business Development
vishal@brandessenceresearch.com
+91 8830 254 358
AjayRana
Ajay Rana
Business Development
ajay@brandessenceresearch.com
+91 7447 409 162
GDPR
1
Fill Details
2
Verify Email
3
Check your inbox for Sample + Methodology

Note: For delivery of sample pages you must have a Domain Specific EmailID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc are not accepted


Segmentation
Segments

By Disease Type: 

  • Von Willebrand Disease 
  • Hemophilia A 
  • Hemophilia B 
  • Others 

By Product Type: 

  • Plasma-derived Factor Concentrate 
  • Desmopressin 
  • Antifibrinolytics 
  • Recombinant Factor Concentrate 
  • Others 

By Route of Administration: 

  • Nasal Spray
  • Injectable 

By Therapy: 

  • Replacement Therapy 
  • Immune Tolerance Induction Therapy 
  • Gene Therapy 
  • Others 

By End-User: 

  • Online 
  • Hospital Pharmacy 
  • Retail Pharmacy 
  • Others 
Country
Regions and Country

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Sweden
  • Netherlands
  • Turkey
  • Switzerland
  • Belgium
  • Rest of Europe

Asia-Pacific

  • South Korea
  • Japan
  • China
  • India
  • Australia
  • Philippines
  • Singapore
  • Malaysia
  • Thailand
  • Indonesia
  • Rest of APAC

Latin America

  • Mexico
  • Colombia
  • Brazil
  • Argentina
  • Peru
  • Rest of South America

Middle East and Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of MEA
Company
Key Players
  • Grifols SA
  • CSL Ltd.
  • Octapharma AG
  • Novo Nordisk
  • Kedrion
  • Pfizer  
  • Bayer AG
  • Biogen Idec  
  • Hospira  
  • Baxter International  
  • and others.

+44-1173181773

sales@brandessenceresearch.com

We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com

JOIN US

LONDON OFFICE

BrandEssence® Market Research and Consulting Pvt ltd.

124, City Road, London EC1V 2NX

FOLLOW US

Twitter
Facebook
LinkedIn
Skype
YouTube

CONTACT US

1-888-853-7040 - U.S. (TOLL FREE)+44-1173181773 - U.K. OFFICE+91-7447409162 - INDIA OFFICE

© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®

PaymentModes